Episode Details

This episode explores the critical challenge MedTech leaders face in 2026 regarding the safe implementation of AI chatbots in healthcare. We discuss how to develop a robust governance model that effectively balances the competing demands of innovation speed, user-friendliness, essential human oversight, and uncompromising patient safety to prevent misleading patients and clinicians. - How can MedTech companies deploy AI chatbots without compromising patient safety? - What does a balanced governance model for clinical AI look like in practice? - What is the "human-in-the-loop" model and why is it essential for medical AI? - How can organizations manage the pressure to innovate quickly while ensuring rigorous validation? - What are the key regulatory and safety considerations for AI influencing care pathways? - How should usability be designed to prevent over-reliance on AI by clinicians? - What are the risks of AI "correctness drift" in a post-market setting? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with a unique blend of local expertise and advanced AI. Our services cover the entire product lifecycle, from regulatory strategy and technical dossier submission to post-market surveillance. By leveraging AI and a network of local experts in over 30 markets, we help you navigate complex regulatory landscapes efficiently. For help getting your medical device to market faster, contact us at info@pureglobal.com, visit https://pureglobal.com/, or explore our free AI tools and database at https://pureglobal.ai.